Skip to main content
. 2022 May 27;65(6):2128–2143. doi: 10.1044/2022_JSLHR-21-00589

Table 1.

Participant stratification and demographic information, as well as onset site, ALSFRS-R score, Human word recognition rate (WRR), and Machine WRR.

Group Clinician-rated severity n
Age (years) M (SD) Onset site (n)
ALSFRS-R M (SD) M (SD; %)
All F M Sp. Bul. Mix. Un. Human WRR Machine WRR
ALS & HC Normal 23 12 11 62.87 (9.31) n/a n/a n/a n/a n/a 97.82 (2.29) 83.12 (14.04)
HC Normal 20 11 9 63.22 (9.37) n/a n/a n/a n/a n/a 98.10 (1.99) 85.45 (13.46)
ALS Normal 3 1 2 60.59 (10.55) 2 0 1 0 38.00 (2.83) 95.96 (3.71) 67.59 (5.60)
ALS Mild 11 4 7 58.59 (8.36) 6 3 1 1 25.78 (10.60) 92.83 (3.41) 76.40 (10.74)
ALS Moderate 11 3 8 58.64 (12.12) 8 2 0 1 30.75 (8.75) 77.13 (17.00) 48.02 (26.09)
ALS Severe 14 4 10 56.28 (11.28) 4 9 1 0 33.22 (9.15) 58.41 (19.62) 17.70 (12.60)
ALS Profound 13 10 3 61.61 (8.14) 5 7 0 1 32.25 (9.94) 18.09 (18.87) 2.86 (4.94)
Overall 72 33 39 60.01 (9.93) 25 21 3 3 31.00 (9.62) 71.84 (32.1) 49.52 (35.81)

Note. F = female; M = male; Sp. = spinal; Bul. = bulbar; Mix. = mixed; Un. = unknown; ALS = participants with ALS diagnosis; HC = healthy controls; n/a = data not collected for HC participants.